» Articles » PMID: 37445926

Endosome Traffic Modulates Pro-Inflammatory Signal Transduction in CD4 T Cells-Implications for the Pathogenesis of Systemic Lupus Erythematosus

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Jul 14
PMID 37445926
Authors
Affiliations
Soon will be listed here.
Abstract

Endocytic recycling regulates the cell surface receptor composition of the plasma membrane. The surface expression levels of the T cell receptor (TCR), in concert with signal transducing co-receptors, regulate T cell responses, such as proliferation, differentiation, and cytokine production. Altered TCR expression contributes to pro-inflammatory skewing, which is a hallmark of autoimmune diseases, such as systemic lupus erythematosus (SLE), defined by a reduced function of regulatory T cells (Tregs) and the expansion of CD4 helper T (Th) cells. The ensuing secretion of inflammatory cytokines, such as interferon-γ and interleukin (IL)-4, IL-17, IL-21, and IL-23, trigger autoantibody production and tissue infiltration by cells of the adaptive and innate immune system that induce organ damage. Endocytic recycling influences immunological synapse formation by CD4 T lymphocytes, signal transduction from crosslinked surface receptors through recruitment of adaptor molecules, intracellular traffic of organelles, and the generation of metabolites to support growth, cytokine production, and epigenetic control of DNA replication and gene expression in the cell nucleus. This review will delineate checkpoints of endosome traffic that can be targeted for therapeutic interventions in autoimmune and other disease conditions.

Citing Articles

Exploring the immunological underpinnings of allergic conjunctivitis: the role of CD4 + T Cells and SLAM expression in ocular surface disease.

Dou X, Zhang W, Zhang X Int Ophthalmol. 2025; 45(1):77.

PMID: 39964412 DOI: 10.1007/s10792-025-03443-3.


Extracellular Vesicles in Triple-Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential.

Das K, Paul S, Ghosh A, Gupta S, Mukherjee T, Shankar P Cancers (Basel). 2023; 15(19).

PMID: 37835573 PMC: 10571545. DOI: 10.3390/cancers15194879.

References
1.
Lai Z, Borsuk R, Shadakshari A, Yu J, Dawood M, Garcia R . Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus. J Immunol. 2013; 191(5):2236-46. PMC: 3777662. DOI: 10.4049/jimmunol.1301005. View

2.
Linker-Israeli M, Bakke A, Kitridou R, Gendler S, Gillis S, Horwitz D . Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J Immunol. 1983; 130(6):2651-5. View

3.
Fernandez D, Bonilla E, Mirza N, Niland B, Perl A . Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus. Arthritis Rheum. 2006; 54(9):2983-8. PMC: 4034146. DOI: 10.1002/art.22085. View

4.
Nacarelli T, Zhang R . NAD metabolism controls inflammation during senescence. Mol Cell Oncol. 2019; 6(4):1605819. PMC: 6548475. DOI: 10.1080/23723556.2019.1605819. View

5.
Hesse J, Siekierka-Harreis M, Steckel B, Alter C, Schallehn M, Honke N . Profound inhibition of CD73-dependent formation of anti-inflammatory adenosine in B cells of SLE patients. EBioMedicine. 2021; 73:103616. PMC: 8524755. DOI: 10.1016/j.ebiom.2021.103616. View